Zobrazeno 1 - 10
of 13
pro vyhledávání: '"T.C. Sigsgaard"'
Autor:
Mogens Herman Hansen, Per Dombernowsky, B. M. B. Schousboe, Jørn Herrstedt, T.C. Sigsgaard, J. Handberg
Publikováno v:
Journal of Clinical Oncology. 15:1690-1696
PURPOSE To investigate the antiemetic effect and tolerability of the 5-hydroxytryptamine3(5-HT3) antagonist ondansetron plus the dopamine D2 antagonist metopimazine versus ondansetron alone in patients receiving platinum-based chemotherapy. PATIENTS
Publikováno v:
Supportive Care in Cancer. 5:38-43
A few studies indicate a dose-response effect of the antiemetic metopimazine. The aim of this study was therefore to investigate the tolerability of increasing doses of metopimazine given orally every 4 h for eleven doses. The dose levels 20 mg, 30 m
Autor:
Ulrik Lassen, Per Dombernowsky, HeineH. Hansen, Paul E. G. Kristjansen, B. Bergman, Kell Østerlind, Mogens Hansen, T.C. Sigsgaard, Fred R. Hirsch
Publikováno v:
Scopus-Elsevier
Summary Purpose: The introduction of platinum compounds and epipodophyllotoxins in combination with vincristine as induction chemotherapy in small-cell lung cancer (SCLC) was investigated in order to: (1) compare the efficacy of cisplatin with that o
Autor:
T.C. Sigsgaard, S. Ottesen, Per Dombernowsky, Jørn Herrstedt, HA Nielsen, Langer Sw, J. Handberg
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 15(4)
To compare the antiemetic efficacy and tolerability of tropisetron plus metopimazine with tropisetron plus placebo during 4 cycles of multiple-day, cisplatin-based chemotherapy.82 chemotherapy-naive patients with germ cell cancer scheduled to 4 cycle
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 19(7)
PURPOSE: To compare the antiemetic efficacy and tolerability of ondansetron plus metopimazine with ondansetron plus metopimazine plus prednisolone during nine cycles of moderately emetogenic chemotherapy. PATIENTS AND METHODS: A total of 221 women wi
Autor:
Lund H, Kjaerbøl Ag, Langer Sw, Mogens Kjaer, T.C. Sigsgaard, Jørn Herrstedt, H Havsteen, L J Andersen, Per Dombernowsky
Publikováno v:
British Journal of Cancer
This randomized, double-blind, double-dummy parallel study compared the anti-emetic efficacy and tolerability of the serotonin antagonist granisetron with prednisolone plus the dopamine D2 antagonist metopimazine during nine cycles of moderately emet
Publikováno v:
The New England journal of medicine. 328(15)
The serotonin (5-hydroxytryptamine3) antagonists have improved the treatment of acute chemotherapy-induced nausea and vomiting, but their ability to prevent delayed nausea and vomiting seems less pronounced. The results of a preliminary open trial su
Autor:
P Philip, Mikael Rørth, S B Gjedde, Dorte Nielsen, P Dombernowsky, S. O. Larsen, Henning T. Mouridsen, Jens Pedersen-Bjergaard, T.C. Sigsgaard, Mogens Hansen
Publikováno v:
Europe PubMed Central
PURPOSE To report five cases of acute monocytic or myelomonocytic leukemia after chemotherapy with 4-epidoxorubicin for breast cancer and to evaluate the risk of leukemia after the use of this drug. PATIENTS AND METHODS One hundred fifty-seven patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d33fe3504843e275a77725cf02f10bf9
http://europepmc.org/abstract/med/1517787
http://europepmc.org/abstract/med/1517787
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.